The relationship between tumor-related hypometabolism in frontal–limbic circuits and depression may prompt potential therapeutic applications of vascular-modulating agents, including those targeting VEGF, or hyperbaric oxygen therapy, which could ultimately improve mood via neurovascular homeostasis [111]. Here, VEGFA is linked to neoplasm.